University of Washington (only Psych students eligible, public not eligible for participation)
Seattle, Washington, 98195, United States
NCT Number: NCT05130307
Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98195, United States
This study will use Quantitative Sensory Testing (computer-controlled brief 10 second thermal pain stimuli) in healthy college students.
The primary aim is to conduct a randomized, controlled study with healthy volunteers to explore whether interacting with virtual objects in VR via a highly immersive VR system makes VR significantly more effective/powerful compared to a less immersive VR system, vs. No VR, for reducing pain during quantitative sensory testing.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
COVID-19 precautions. Vaccinated: Individuals are considered fully vaccinated 2 weeks after the second dose in a 2-dose series (e.g., Pfizer or Moderna) or 2 weeks after a single-dose vaccine (e.g., Johnson & Johnson).
All students and researchers must wear masks at all times during the study, and participants and researchers must provide proof of full vaccination for full participation.
If participants do not have proof of vaccination or are unvaccinated, they are still free to sign up for the study. They are invited. They can still earn the extra credit by reading educational materials, in person, during their scheduled time slot. If unvaccinated, or if they have no proof of vaccination, we request that students provide proof of a negative COVID-19 test from the UW test site at the faculty lounge, dated within 24 hours of the study (non-vaccinated students need a recent negative COVID-19 test from the UW before participating in the non-VR educational materials option.
-
Exclusion criteria
The following temporary inclusion/exclusion criterion will exist only as long as required or appropriate for COVID pandemic conditions.
COVID-19 precautions. Vaccinated: Individuals are considered fully vaccinated 2 weeks after the second dose in a 2-dose series (e.g., Pfizer or Moderna) or 2 weeks after a single-dose vaccine (e.g., Johnson & Johnson).
All students and researchers must wear masks at all times during the study, and participants and researchers must provide proof of full vaccination for full participation.
If participants do not have proof of vaccination or are unvaccinated, they are still free to sign up for the study. They are invited. They can still earn the extra credit by reading educational materials, in person, during their scheduled time slot. If unvaccinated, or if they have no proof of vaccination, we request that students provide proof of a negative COVID-19 test from the UW test site at the faculty lounge, dated within 24 hours of the study.
participants interact with a computer generated world
Time frame: Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Baseline, Worst pain rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Time frame: Immediately after each single 10 second test stimulus (< 10 minutes after baseline pain rating)
Test phase, Worst pain rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Time frame: Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Baseline Time thinking, Single a single graphic rating scale, 0 = none of the time, 10 = all of the time
Time frame: Immediately after each single 10 second test stimulus (< 10 minutes after baseline pain rating)
Test phase, Time rating, using a single graphic rating scale, 0 = none of the time, 10 = all of the time
Time frame: Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Baseline, Unpleasant rating, using single graphic rating scale, 0 = not unpleasant at all, 10 = excruciatingly unpleasant
Time frame: Immediately after each single 10 second test stimulus (< 10 minutes after baseline pain rating)
Test phase, pain unpleasantness, 0 = not unpleasant at all, 10 = excruciatingly unpleasant
Time frame: Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Baseline fun, 0 = no fun at all, 10 = extremely fun
Time frame: Immediately after each single 10 second test stimulus (< 10 minutes after baseline fun rating)
Test phase fun, 0 = no fun at all, 10 = extremely fun
Time frame: Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Baseline, pain intensity rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Time frame: No pain during this measure, measured within 10 minutes after the QST measures are completed.
participants accuracy on the attention demanding "odd number" task (Hoffman, 2021)
University of Washington
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07249827
Acute Pain, Agnosia
Montreal, Quebec, Canada
View Trial DetailsNCT07053774
Acute Pain, Agnosia
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06282666
Acute Pain, Agnosia
Lublin, Poland
View Trial DetailsNCT05575700
Acute Pain, Agnosia
Brøndby, Denmark
View Trial Details